This is exciting Karin, I will look into this for my family member. Thank you. I read the paper and there is no mention of preclinical work with DNaseI for AD. Very strange. What possessed them to try this.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.